Qualigen Therapeutics Stock Price History

QLGN Stock  USD 3.55  0.07  1.93%   
Below is the normalized historical share price chart for Qualigen Therapeutics extending back to June 24, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Qualigen Therapeutics stands at 3.55, as last reported on the 23rd of February, with the highest price reaching 3.63 and the lowest price hitting 3.37 during the day.
IPO Date
24th of June 2015
200 Day MA
8.1068
50 Day MA
3.8814
Beta
0.127
 
Yuan Drop
 
Covid
If you're considering investing in Qualigen Stock, it is important to understand the factors that can impact its price. Qualigen Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.0722, which implies the firm had a -0.0722 % return per unit of risk over the last 3 months. Qualigen Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Qualigen Therapeutics' Risk Adjusted Performance of 0.0019, variance of 30.25, and Coefficient Of Variation of (10,908) to confirm the risk estimate we provide.
  
At this time, Qualigen Therapeutics' Common Stock Shares Outstanding is very stable compared to the past year. As of the 23rd of February 2025, Capital Stock is likely to grow to about 66.5 K, though Total Stockholder Equity is likely to grow to (1.8 M). . As of the 23rd of February 2025, Price To Sales Ratio is likely to drop to 29.27. In addition to that, Price Earnings Ratio is likely to drop to -9.82. Qualigen Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0722

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsQLGN

Estimated Market Risk

 5.05
  actual daily
45
55% of assets are more volatile

Expected Return

 -0.36
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.07
  actual daily
0
Most of other assets perform better
Based on monthly moving average Qualigen Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Qualigen Therapeutics by adding Qualigen Therapeutics to a well-diversified portfolio.
Price Book
0.4055
Enterprise Value Ebitda
(0.05)
Price Sales
0.3869
Shares Float
736 K
Wall Street Target Price
5

Qualigen Therapeutics Stock Price History Chart

There are several ways to analyze Qualigen Stock price data. The simplest method is using a basic Qualigen candlestick price chart, which shows Qualigen Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceNovember 22, 20244.83
Lowest PriceJanuary 28, 20253.12

Qualigen Therapeutics February 23, 2025 Stock Price Synopsis

Various analyses of Qualigen Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Qualigen Stock. It can be used to describe the percentage change in the price of Qualigen Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Qualigen Stock.
Qualigen Therapeutics Price Action Indicator 0.01 
Qualigen Therapeutics Price Rate Of Daily Change 0.98 
Qualigen Therapeutics Price Daily Balance Of Power(0.27)

Qualigen Therapeutics February 23, 2025 Stock Price Analysis

100%
When benchmark price declines in a down market, there may be an uptick in Qualigen Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Qualigen Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Qualigen Stock and then apply it to test your longer-term investment strategies against Qualigen.

Qualigen Stock Price History Data

The price series of Qualigen Therapeutics for the period between Mon, Nov 25, 2024 and Sun, Feb 23, 2025 has a statistical range of 1.71 with a coefficient of variation of 11.46. The price distribution for the period has arithmetic mean of 4.0. The median price for the last 90 days is 4.05. The company completed stock split (1:50) on 5th of November 2024. Qualigen Therapeutics had dividends distributed to its stock-holders on 2020-05-26.
OpenHighLowCloseVolume
02/23/2025
 3.52  3.63  3.37  3.55 
02/21/2025 3.52  3.63  3.37  3.55  11,061 
02/20/2025 3.50  3.71  3.50  3.62  10,986 
02/19/2025 3.52  3.74  3.52  3.53  4,901 
02/18/2025 3.65  3.75  3.54  3.60  8,148 
02/14/2025 3.37  3.74  3.32  3.65  34,964 
02/13/2025 3.31  3.45  3.28  3.38  11,353 
02/12/2025 3.30  3.31  3.25  3.31  23,683 
02/11/2025 3.22  3.30  3.16  3.23  43,155 
02/10/2025 3.21  3.31  3.21  3.22  7,820 
02/07/2025 3.48  3.48  3.25  3.26  12,337 
02/06/2025 3.33  3.43  3.26  3.38  36,959 
02/05/2025 3.36  3.38  3.28  3.30  23,489 
02/04/2025 3.38  3.59  3.32  3.45  54,742 
02/03/2025 3.25  3.50  3.14  3.50  57,168 
01/31/2025 3.36  3.37  3.12  3.27  31,063 
01/30/2025 3.40  3.50  3.25  3.41  54,469 
01/29/2025 2.96  3.79  2.96  3.34  194,973 
01/28/2025 4.04  4.04  2.99  3.12  1,168,138 
01/27/2025 4.30  4.30  3.97  3.97  340,098 
01/24/2025 4.50  4.58  4.25  4.25  86,274 
01/23/2025 4.23  4.34  4.08  4.34  31,941 
01/22/2025 4.26  4.28  4.08  4.21  11,533 
01/21/2025 4.08  4.33  4.08  4.18  15,309 
01/17/2025 4.03  4.15  4.00  4.07  5,004 
01/16/2025 3.99  4.09  3.99  4.00  10,930 
01/15/2025 4.16  4.21  3.95  3.95  15,329 
01/14/2025 4.13  4.13  4.05  4.05  7,917 
01/13/2025 4.35  4.35  4.03  4.10  9,403 
01/10/2025 4.20  4.31  3.90  4.28  21,153 
01/08/2025 4.28  4.44  4.15  4.17  18,089 
01/07/2025 4.65  4.66  4.37  4.40  17,028 
01/06/2025 4.55  4.67  4.34  4.51  31,398 
01/03/2025 4.22  4.59  4.22  4.54  37,993 
01/02/2025 4.23  4.27  4.18  4.20  11,566 
12/31/2024 4.00  4.47  4.00  4.21  33,280 
12/30/2024 4.13  4.23  3.90  4.11  39,845 
12/27/2024 4.40  4.40  4.06  4.27  30,157 
12/26/2024 4.03  4.40  4.03  4.30  44,056 
12/24/2024 3.96  4.12  3.90  4.03  14,815 
12/23/2024 3.99  4.04  3.91  4.04  3,849 
12/20/2024 4.05  4.16  3.90  3.90  30,720 
12/19/2024 3.90  4.14  3.90  4.04  22,490 
12/18/2024 4.19  4.19  3.90  3.90  9,166 
12/17/2024 4.29  4.30  4.05  4.23  10,438 
12/16/2024 3.85  4.39  3.81  4.39  108,603 
12/13/2024 3.78  3.87  3.53  3.87  26,315 
12/12/2024 3.90  4.03  3.60  3.76  38,327 
12/11/2024 4.28  4.37  3.87  3.90  62,699 
12/10/2024 4.60  4.64  4.25  4.28  28,569 
12/09/2024 4.55  4.68  4.46  4.50  8,878 
12/06/2024 4.61  4.72  4.46  4.48  32,012 
12/05/2024 4.57  4.79  4.45  4.53  67,536 
12/04/2024 4.60  4.80  4.43  4.74  29,380 
12/03/2024 4.60  4.75  4.38  4.53  40,763 
12/02/2024 4.57  4.71  4.38  4.69  14,701 
11/29/2024 4.77  4.77  4.49  4.62  17,126 
11/27/2024 4.44  4.71  4.33  4.66  33,927 
11/26/2024 4.71  4.71  4.14  4.47  68,739 
11/25/2024 5.05  5.05  4.41  4.78  174,259 
11/22/2024 4.45  5.00  4.34  4.83  137,939 

About Qualigen Therapeutics Stock history

Qualigen Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Qualigen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Qualigen Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Qualigen Therapeutics stock prices may prove useful in developing a viable investing in Qualigen Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding5.8 M6.1 M
Net Loss-16.8 M-17.6 M

Qualigen Therapeutics Stock Technical Analysis

Qualigen Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Qualigen Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Qualigen Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Analyzer Now

   

Portfolio Analyzer

Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
All  Next Launch Module

Qualigen Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Qualigen Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Qualigen Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Qualigen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Qualigen Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Qualigen Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Qualigen Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Qualigen Therapeutics Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Qualigen Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
To learn how to invest in Qualigen Stock, please use our How to Invest in Qualigen Therapeutics guide.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Qualigen Therapeutics. If investors know Qualigen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Qualigen Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
3.6 K
Revenue Per Share
1.034
Quarterly Revenue Growth
0.137
Return On Assets
(1.26)
Return On Equity
(8.42)
The market value of Qualigen Therapeutics is measured differently than its book value, which is the value of Qualigen that is recorded on the company's balance sheet. Investors also form their own opinion of Qualigen Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Qualigen Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Qualigen Therapeutics' market value can be influenced by many factors that don't directly affect Qualigen Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Qualigen Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Qualigen Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Qualigen Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.